m
Recent Posts
Connect with:
Wednesday / April 24.
HomemiequipmentNew Myopia Management CL Launched

New Myopia Management CL Launched

Mark’ennovy has launched Mylo, a new contact lens to manage myopia, which is powered by Brien Holden Vision Institute’s Extended Depth of Focus technology.

Myopia’s impact on vision and ocular health, along with its growing prevalence among the general population, is of growing concern among the eye care sector. Studies estimate that myopia will affect five billion people worldwide by 2050, while in Europe the myopic population will increase from 22% to 56% within the next 30 years.1

The lens design provides a signal to slow eye growth by degrading the quality of the image behind the eye and therefore reducing the risk of the eye growing posteriorly

More than the refractive error itself, myopia threatens to increase the onset of adverse ocular complications. The higher the amount of myopia, the higher the incidence of cataracts, glaucoma, retinal detachment and myopic maculopathy – all of which have the potential to not only cause vision impairment and/or blindness, but also increase the public health burden and financial costs associated with the refractive error.

George Sarrouf, CEO & Chairman at mark’ennovy, said, “Considering the growing prevalence of myopia, the eye care sector is faced with a great responsibility to minimise the alarming consequences it can have on a patient’s long-term vision and eye health. With Mylo, our new soft contact lens specifically designed for myopia management, mark’ennovy partnering with the Brien Holden Vision Institute have set out to keep myopia low among the general population.”

Professor Padmaja Sankaridurg, Head of Brien Holden Vision Institute’s Global Myopia Centre explained, “The performance of Mylo is the result of the lens’ Extended Depth of Focus design. The lens design provides a signal to slow eye growth by degrading the quality of the image behind the eye and therefore reducing the risk of the eye growing posteriorly”.

Mylo has been granted CE marking as a medical device specifically for Myopia Management. It is individually crafted from mark’ennovy’s silicone hydrogel material and is now available as a monthly replacement in a broader range of base curves and diameters.

References
1. Holden et al. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Ophthalmology. May 2016.